Crossmark

Construction and validation of a recurrence prediction model for lung adenocarcinoma after treatment integrating radiomics features and clinical indicators

Crossref DOI link: https://doi.org/10.1186/s12885-025-15427-8

Published Online: 2025-12-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Liao, Ruomin

Zhang, Yi

Li, Gang
License Information

Text and Data Mining valid from 2025-12-10

Version of Record valid from 2026-01-21
More Information

Article History

Received: 9 October 2025

Accepted: 3 December 2025

First Online: 10 December 2025

Declarations

:

: This retrospective study was conducted in accordance with the ethical principles of the Helsinki Declarationand its later amendments. The Institutional Review Board (IRB) of Shanghai People’s Hospital reviewed the protocol and waived the requirement for formal informed consent due to the use of fully anonymized and de-identified patient data. Data confidentiality was strictly maintained throughout the study to protect patient privacy.

: Not Applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below